We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring
Webinar

Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring
Webinar

Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

Clare Paterson, PhD
Clare Paterson, PhD
Associate Director of Clinical Research, SomaLogic
Jessica Chadwick, PhD
Jessica Chadwick, PhD
Scientist, SomaLogic

In this webinar you’ll learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology ‒ from monitoring the cardiotoxic effects of chemotherapy treatment to developing blood-based protein-only tests for stratifying lung cancer susceptibility.

 

Watch this webinar to discover how:

  • Proteomic risk scores can be used to identify high risk patients and monitor for adverse effects
  • To analyze thousands of proteins to develop cancer susceptibility models
    High-throughput proteomics can inform and impact patients' standard of care
Advertisement